Disc Medicine’s (IRON) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $70.00 price objective on the stock. Other research analysts have also recently issued research reports about the stock. Stifel Nicolaus boosted their price objective on […]
More Stories
Insider Selling: Paragon 28, Inc. (NYSE:FNA) Major Shareholder Sells 4,256 Shares of Stock
Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 4,256 shares of Paragon 28 stock...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Sells $144,631.36 in Stock
IDEXX Laboratories, Inc. (NASDAQ:IDXX – Get Free Report) Director Sophie V. Vandebroek sold 344 shares of the stock in a...
Contrasting TruGolf (TRUG) and Its Competitors
Volatility and Risk TruGolf has a beta of -0.67, suggesting that its share price is 167% less volatile than the...
Brighthouse Financial, Inc. (NASDAQ:BHFAN) Short Interest Update
Brighthouse Financial, Inc. (NASDAQ:BHFAN – Get Free Report) was the recipient of a large drop in short interest during the...
Baosheng Media Group Holdings Limited (NASDAQ:BAOS) Sees Large Growth in Short Interest
Baosheng Media Group Holdings Limited (NASDAQ:BAOS – Get Free Report) saw a large increase in short interest in the month...
Short Interest in Bridgeline Digital, Inc. (NASDAQ:BLIN) Declines By 66.1%
Bridgeline Digital, Inc. (NASDAQ:BLIN – Get Free Report) saw a large drop in short interest during the month of November....